Uploaded June 2025 | Updated September 2026, 1 week ago
In our new episode, we sit down with Jennifer Krohn, Associate Director of Risk-Based Quality Management at Gilead Sciences, to explore how centralized monitoring is enhancing data quality, participant safety, and operational efficiency across clinical trials.
Jenn breaks down the power of early signal detection through statistical tools and AI, the role of CRA training in quality oversight, and how the open-source community is driving cross-functional collaboration in pharma.
➡️ Click the episode link right above the description to watch the full video!
In our new episode, we sit down with Jennifer Krohn, Associate Director of Risk-Based Quality Management at Gilead Sciences, to explore how centralized monitoring is enhancing data quality, participant safety, and operational efficiency across clinical trials.
Jenn breaks down the power of early signal detection through statistical tools and AI, the role of CRA training in quality oversight, and how the open-source community is driving cross-functional collaboration in pharma.
➡️ Click the episode link right above the description to watch the full video!










